Striving for significant outcomes
Professor Khalid Matalka received his BSc and MSc in Medical Technology in 1986 and 1988 from Yarmouk University, Jordan, and the University of Wisconsin-Milwaukee, USA. Then he received his Ph.D. in Pathology (Immunology and Cancer therapy) from Ohio State University, USA, in 1992. After finishing his Ph.D., Dr. Matalka joined Harvard Medical School as a Postdoctoral fellow till 1994. He is an American Board Certified as a Specialist in Immunology (SI (ASCP) and a member at the American Society for Cancer Research since 1994.
Dr. Matalka enrolled in academia as an assistant professor in 1995. Dr. Matalka got promoted from assistant to associate and then a professor in 9 years. Prof. Matalka held a dean position at two different academic institutions, the University of Petra and the American University of Madaba. Besides, Prof. Matalka was a consultant for a JPM pharmaceutical company and a hospital diagnostic laboratory. In 2016, he joined a pharmaceutical startup company named OncoTherapeutica, as a Chief Biologist. While there, Prof. Matalka was developing new potential drugs for the treatment of prostate cancer and melanoma.
Prof. Matalka has 63 publications in peer-reviewed international journals, and he is an Associate Editor of two and a member of the editorial board of several international journals. Prof. Matalka is known as an international reviewer in the fields of Cancer therapy, Immunomodulation, and Ethnopharmacology.
Because of his passion for scientific and medical writing, Prof. Matalka recently established a scientific writing consultation (https://matalkascientificwriting.com). He believes that scientific writing is a hybrid of compelling science and art of presentation while maintaining a positive mindset, focused with a purpose, and always striving for significant outcomes.
Either by hourly rate or by the project.